For more than 20 years, virologist Matt Frieman has dedicated his career to the study of coronaviruses. So for a good part of his professional life, an introduction at a cocktail party required that he first explain what epidemiology was followed by a justification for exclusively studying novel coronaviruses. Of course, that was before the COVID-19 pandemic. His specific area of expertise has now arguably become one of the most important and relevant areas of global scientific inquiry. As his work continues, he is focusing on the search for a cure to all SARS-coronaviruses in the quest to avoid the next global pandemic before it begins.
***VIP Q&A After the Main Event***
If you donated $100 or more in the past 12 months or donate at the $20 level for this event, you’ll have the opportunity to join our 30 minute VIP Q&A right after the main event at around 2PM PST/5PM EST and speak directly with Matt. We’ll reach out to those donors with more details.
Speaker:
Matthew Frieman’s overall research goal is to create therapeutic interventions for coronaviruses by developing a detailed understanding of how they interact with the host. His recent research has focused on identifying novel and repurposed drugs, antibodies, and vaccines for Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2/COVID19), leveraging all of his previous work on the previously emerged highly pathogenic coronaviruses Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome Coronavirus (MERS-CoV).
